Engagement note
What the First 90 Days Look Like
For AI-platform companies selling capabilities into pharma — target discovery, patient stratification, dose optimization, biomarker development. The biotech-shaped variant lives here.
The detailed phase-by-phase content for this engagement note is being prepared for the website. JGN has reviewed and marked the canonical version in the vault; the public-facing version is integrated here pending final layout polish.
Placeholder note. This page will hold the full text of the AI-platform 90-Days engagement note, including the partner-facing toolkit (Platform Validation Package, Partner Q&A Library, Reasoned-Departure Support), the underlying-commercial-question framing, the platform-portfolio Calibration Map decision fields, and the Strategic Theme one-pager as the Phase 4 portable summary.
The full vault source — including the v1.4 calibration-map decision fields you marked — will be integrated into this page once the JGN markup is shared and reconciled with the website's typographic conventions.